Article Information
History
- January 9, 2020.
Article Versions
- You are currently viewing Version 1 of this article (January 9, 2020 - 08:33).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mie F. Pedersen1,3,
- Thor C. Møller1,3,*,
- Sofie D. Seiersen1,
- Jesper M. Mathiesen1,
- Michel Bouvier2 and
- Hans Bräuner-Osborne.1,*
- 1Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark
- 2Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer, Université of Montréal, Montreal, QC, Canada
- ↵*Co-corresponding authors: thor.moller{at}sund.ku.dk; hbo{at}sund.ku.dk
↵3 These authors contributed equally to this work